Agilent Technologies Inc at Barclays Global Healthcare Conference Transcript
[Good noon,] everybody. Luke Sergott. I cover the Life Science Tools and Diagnostics here at Barclays. I think I got that part right. Today, I have Bob McMahon with me, CFO of Agilent. It's great to have you here.
Questions & Answers
To start off key questions on all the investment right now is trying to -- there's been a lot of confusion on how the [growth] was trended particularly in LSAG throughout the quarter. So I want to dive in there and talk about the trends that you're seeing and ultimately, how the backlog built order did not...
Yes. As well, it's great to be here and particularly coming from California where never-ending rain. It's good to see, although today (inaudible) but certainly appreciate you being -- having the opportunity to talk to (inaudible) and talk with I would
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |